This work is licensed under a Creative Commons Attribution 4.0 International License.
LK
General Information
DRACP ID DRACP06064
Peptide Name LK
Sequence LKKLLKLLKKLLKL
Sequence Length 14
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Membrane-targeted
Activity Information
Hemolytic Activity Mouse red blood cells:Hemolysis rate=48%=50μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C84H162N20O15
Absent amino acids ACDEFGHIMNPQRSTVWY
Common amino acids L
Mass 192442
Pl 11.5
Basic residues 6
Acidic residues 0
Hydrophobic residues 8
Net charge 6
Boman Index 606
Hydrophobicity 50
Aliphatic Index 222.86
Half Life
Mammalian:
Yeast:
E.coli:
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110862458A
Patent Title Combined peptide with acid-activated anti-tumor activity and clinical application of combined peptide
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.